Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

B Dubois, HH Feldman, C Jacova, ST DeKosky… - The Lancet …, 2007 - thelancet.com
The NINCDS–ADRDA and the DSM-IV-TR criteria for Alzheimer's disease (AD) are the
prevailing diagnostic standards in research; however, they have now fallen behind the …

Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial

B Vellas, N Coley, PJ Ousset, G Berrut… - The Lancet …, 2012 - thelancet.com
Background Prevention strategies are urgently needed to tackle the growing burden of
Alzheimer's disease. We aimed to assess efficacy of long-term use of standardised ginkgo …

Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?

P Celsis - Annals of medicine, 2000 - Taylor & Francis
With the promising development of effective treatment, significant improvement in the very
early diagnosis of Alzheimer's disease (AD) is required. There is vast agreement that a …

Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study

H Amieva, C Meillon, C Helmer, P Barberger-Gateau… - PLoS …, 2013 - journals.plos.org
Background Numerous studies have looked at the potential benefits of various nootropic
drugs such as Ginkgo biloba extract (EGb761®; Tanakan®) and piracetam (Nootropyl®) on …

[HTML][HTML] The primary care physician and Alzheimer's disease: an international position paper

H Villars, S Oustric, S Andrieu, JP Baeyens… - The Journal of nutrition …, 2010 - Elsevier
This paper aims to define the role of the primary care physician (PCP) in the management of
Alzheimer's disease (AD) and to propose a model for a work plan. The proposals in this …

Executive functions in clinical and preclinical Alzheimer's disease

P Allain, F Etcharry-Bouyx, C Verny - Revue neurologique, 2013 - Elsevier
Executive functions is an umbrella term describing a wide range of higher order processes
that allow the flexible modification of thought and behaviour in response to changing …

Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment

MO Habert, JF Horn, M Sarazin, JA Lotterie, M Puel… - Neurobiology of …, 2011 - Elsevier
OBJECTIVE: To improve diagnosis of early Alzheimer's disease (AD), ie, prodromal AD, by
an automated quantitative tool combining brain perfusion single-photon emission computed …

Neuropsychological signs of Alzheimer's disease 8 years prior to diagnosis

NS Schmid, KI Taylor, NS Foldi… - Journal of …, 2013 - content.iospress.com
We investigated the earliest neuropsychological changes in Alzheimer's disease (AD) by
comparing the baseline performance of 29 individuals who subsequently developed AD …

GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale …

S Andrieu, PJ Ousset, N Coley, M Ouzid… - Current Alzheimer …, 2008 - ingentaconnect.com
Primary and secondary prevention strategies for Alzheimer's disease (AD) are urgently
needed. We have initiated a five-year prospective prevention study involving patients …

The GuidAge study: Methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761® for prevention of Alzheimer disease in patients over 70 …

B Vellas, S Andrieu, PJ Ousset, M Ouzid… - Neurology, 2006 - AAN Enterprises
Background: Preventive approaches in the field of Alzheimer disease (AD) is important but
these trials raise many questions. Which protective factor should be studied? What …